JF
IRON icon

Jump Financial’s Disc Medicine IRON Stock Holding History

Jump Financial’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.38M Sell
32,549
-49,280
-60% -$3.39M 0.02% 821
2026
Q1 		$5.23M Buy
+81,829
New +$5.68M 0.07% 343
2025
Q1 		– Sell
-11,507
Closed -$730K – 1805
2024
Q4 		$730K Buy
+11,507
New +$666K 0.02% 898
2024
Q3 		– Sell
-9,475
Closed -$427K – 1878
2024
Q2 		$427K Buy
+9,475
New +$322K 0.01% 1196
2024
Q1 		– Sell
-4,306
Closed -$249K – 2081
2023
Q4 		$249K Buy
+4,306
New +$220K 0.01% 1440

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jump Financial's IRON Position: Q2 2026 in Review

Jump Financial reduced its Disc Medicine (IRON) stake by 60% in Q2 2026, selling an estimated $3.39M and leaving 32,549 shares worth $2.38M. The position accounts for 0.02% of the portfolio, ranked #821.

Jump Financial first reported a position in IRON in Q4 2023 and has held it in 5 quarters since. The position peaked at $5.23M in Q1 2026. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Jump Financial held 32,549 shares of Disc Medicine worth $2.38M as of Q2 2026.
  • Jump Financial sold 49,280 Disc Medicine shares in Q2 2026, an estimated $3.39M.
  • Disc Medicine made up 0.02% of Jump Financial's portfolio in Q2 2026, its #821 holding.
  • Jump Financial first reported a position in Disc Medicine in Q4 2023 and has held it in 5 quarters since.
  • Jump Financial's Disc Medicine position peaked at $5.23M in Q1 2026.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.